載入...
The MelFo Study UK: Effects of a Reduced-Frequency, Stage-Adjusted Follow-Up Schedule for Cutaneous Melanoma 1B to 2C Patients After 3-Years
BACKGROUND: Evidence-based guidelines for follow-up treatment of American Joint Committee on Cancer (AJCC) stages 1B to 2C melanoma patients are lacking. The MELanoma FOllow-up study is an international phase 3 randomized trial, and the 3-year interim data were recently reported from the Netherlands...
Na minha lista:
| 發表在: | Ann Surg Oncol |
|---|---|
| Main Authors: | , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Springer International Publishing
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7497689/ https://ncbi.nlm.nih.gov/pubmed/32623608 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1245/s10434-020-08758-2 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|